检索结果 - Wasat Mansoor

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
    Corneal Confocal Microscopy Detects Small Fibre Neuropathy in Patients with Upper Gastrointestinal Cancer and Nerve Regeneration in Chemotherapy Induced Peripheral Neuropathy

    Corneal Confocal Microscopy Detects Small Fibre Neuropathy in Patients with Upper Gastrointestinal Cancer and Nerve Regeneration in Chemotherapy Induced Peripheral Neuropathy 由 Maryam Ferdousi, Shazli Azmi, Ioannis N. Petropoulos, Hassan Fadavi, Georgios Ponirakis, Andrew Marshall, Mitra Tavakoli, Imaan Malik, Wasat Mansoor, Rayaz A. Malik

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine Carcinomas

    Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine Carcinomas 由 Melissa Frizziero, Francesca Spada, Ángela Lamarca, Zoe Kordatou, Jorge Barriuso, Christina Nuttall, Mairéad G. McNamara, Richard Hubner, Wasat Mansoor, Prakash Manoharan, Nicola Fazio, Juan W. Valle

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification

    A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene... 由 Eric Van Cutsem, Yu Jeong Bang, Wasat Mansoor, Russell Petty, Yee Chao, David Cunningham, D. Ferry, Neil R. Smith, Paul Frewer, Jayantha Ratnayake, Paul K. Stockman, Elaine Kilgour, Dónal Landers

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial

    Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial 由 Hugo Ford, Andrea Marshall, John Bridgewater, Tobias Janowitz, Fareeda Y. Coxon, Jonathan Wadsley, Wasat Mansoor, D. Fyfe, Srinivasan Madhusudan, Gary Middleton, Daniel Swinson, Stephen Falk, Ian Chau, David Cunningham, Paula Kareclas, Natalie Cook, Jane Blazeby, Janet Dunn

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial

    Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, o... 由 David Cunningham, Sally Stenning, Elizabeth Smyth, Alicia Okines, William Allum, Sam Rowley, Laura Stevenson, Heike I. Grabsch, Derek Alderson, T. Crosby, S M Griffin, Wasat Mansoor, Fareeda Y. Coxon, Stephen Falk, Suzanne Darby, Kate Sumpter, Jane Blazeby, Ruth E. Langley

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181

    Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181 由 Antoine Adenis, Amit S. Kulkarni, Gustavo Girotto, Christelle de la Fouchardière, Hélène Senellart, Hanneke W. M. van Laarhoven, Wasat Mansoor, Raed Moh’d Taiseer Al-Rajabi, Josephine M. Norquist, Mayur M. Amonkar, Shailaja Suryawanshi, Pooja Bhagia, Jean‐Philippe Metges

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres

    Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres 由 Melissa Frizziero, Xin Wang, Bipasha Chakrabarty, Alexa Childs, Tu Vinh Luong, Thomas Walter, Mohid S. Khan, Meleri Morgan, Adam Christian, Mona Elshafie, Tahir Shah, Annamaria Minicozzi, Wasat Mansoor, Tim Meyer, Ángela Lamarca, Richard Hubner, Juan W. Valle, Mairéad G. McNamara

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial

    Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phas... 由 Thomas K. Waddell, Ian Chau, David Cunningham, David González, Alicia Okines, Andrew Wotherspoon, Claire Saffery, Gary Middleton, Jonathan Wadsley, David Ferry, Wasat Mansoor, Tom Crosby, Fareeda Y. Coxon, David A. Smith, Justin S. Waters, Timothy Iveson, Stephen Falk, Sarah Slater, Clare Peckitt, Yolanda Barbáchano

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant?

    Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant? 由 Melissa Frizziero, Alice Durand, Rodrigo G. Taboada, Elisa Zaninotto, Claudio Luchini, Bipasha Chakrabarty, Valérie Hervieu, Laura Carolina López Claro, Cong Zhou, Sara Cingarlini, Michèle Milella, Thomas Walter, Rachel P. Riechelmann, Ángela Lamarca, Richard Hubner, Wasat Mansoor, Juan W. Valle, Mairéad G. McNamara

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues

    Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues 由 Edward M. Wolin, Barbara Jarząb, Barbro Eriksson, Thomas Walter, Christos Toumpanakis, Michael A. Morse, Paola Tomassetti, Matthias M. Weber, David R. Fogelman, John Ramage, Donald Poon, Brian Gadbaw, Li Jiang, Janice L. Pasieka, Abakar Mahamat, Fredrik Swahn, John Newell‐Price, Wasat Mansoor, Kjell Öberg

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial

    Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial 由 Susan Dutton, David Ferry, Jane Blazeby, Haider Abbas, Åsa Dahle-Smith, Wasat Mansoor, Joyce Thompson, Mark Harrison, Anirban Chatterjee, Stephen Falk, Angel Garcia-Alonso, D. Fyfe, Richard Hubner, Tina Gamble, Lynnda Peachey, Mina Davoudianfar, Sarah Pearson, Patrick Julier, Janusz Jankowski, Rachel Kerr, Russell Petty

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Pembrolizumab + chemotherapy for advanced G/GEJ adenocarcinoma (GC): The phase III KEYNOTE-062 study

    Pembrolizumab + chemotherapy for advanced G/GEJ adenocarcinoma (GC): The phase III KEYNOTE-062 study 由 Hyun Cheol Chung, Yung‐Jue Bang, Josep Tabernero, Eric Van Cutsem, Charles S. Fuchs, Lucjan Wyrwicz, K.-W. Lee, Iveta Kudaba, Marcelo Garrido, Hugo R. Castro, Wasat Mansoor, Maria Ignez Braghiroli, Eray Goekkurt, Joseph Chao, Zev A. Wainberg, Uma Kher, Shefaat Ullah Shah, Kohei Shitara

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    LBA8_PR Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE-590 study

    LBA8_PR Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE-590 study 由 Ken Kato, J-M. Sun, Manan Shah, Peter C. Enzinger, Antoine Adenis, Toshihiko Doi, Takashi Kojima, J-P. Metges, Zhouxiao Li, S-B Kim, B.C. Chul Cho, Wasat Mansoor, SH Li, Patrapim Sunpaweravong, María Maqueda, Eray Goekkurt, Q. Liu, Sukrut Shah, Pooja Bhagia, Lin Shen

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trial

    Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, contro... 由 Kohei Shitara, Maria Di Bartolomeo, Mario Mandalà, Min‐Hee Ryu, Christian Caglevic, Tomasz Olesiński, Hyun Cheol Chung, Kei Muro, Eray Goekkurt, Ray McDermott, Wasat Mansoor, Zev A. Wainberg, Chie‐Schin Shih, Julie Kobie, Michael Nebozhyn, Rǎzvan Cristescu, Z. Alexander Cao, Andrey Loboda, Mustafa Özgüroğlu

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Gefitinib and <i>EGFR</i> Gene Copy Number Aberrations in Esophageal Cancer

    Gefitinib and <i>EGFR</i> Gene Copy Number Aberrations in Esophageal Cancer 由 Russell Petty, Åsa Dahle-Smith, David A. Stevenson, Aileen Osborne, Doreen Massie, Caroline Clark, Graeme I. Murray, Susan Dutton, Corran Roberts, Irene Chong, Wasat Mansoor, Joyce Thompson, Mark Harrison, Anirban Chatterjee, Stephen Falk, Sean Elyan, Angel Garcia-Alonso, D. Fyfe, Jonathan Wadsley, Ian Chau, David Ferry, Zosia Miedzybrodzka

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial

    Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre,... 由 Piero Ferollà, Maria Pia Brizzi, Tim Meyer, Wasat Mansoor, Julien Mazières, Christine Do Cao, H. Léna, Alfredo Berruti, Vincenzo Damiano, Wieneke A. Buikhuisen, Henning Grønbæk, Catherine Lombard‐Bohas, Christian Grohé, Vincenzo Minotti, Marcello Tiseo, Javier de Castro, Nicholas Reed, Gabriella Gislimberti, Neha Singh, Miona Stankovic, Kjell Öberg, Éric Baudin

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer

    Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer 由 Kohei Shitara, Eric Van Cutsem, Yung‐Jue Bang, Charles S. Fuchs, Lucjan Wyrwicz, Keun‐Wook Lee, Iveta Kudaba, Marcelo Garrido, Hyun Cheol Chung, Jeeyun Lee, Hugo R. Castro, Wasat Mansoor, Maria Ignez Braghiroli, Nina Karaseva, Christian Caglevic, Luis J. Villanueva-Rivera, Eray Goekkurt, Hironaga Satake, Peter C. Enzinger, María Alsina, Al B. Benson, Joseph Chao, Andrew H. Ko, Zev A. Wainberg, Uma Kher, Sukrut Shah, Soonmo Peter Kang, Josep Tabernero

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

    Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma 由 Yuichiro� Doki, Jaffer A. Ajani, Ken Kato, Jianming Xu, Lucjan Wyrwicz, Satoru Motoyama, Takashi Ogata, Hisato Kawakami, Chih‐Hung Hsu, Antoine Adenis, Farid El Hajbi, Maria Di Bartolomeo, Maria Ignez Braghiroli, Eva Holtved, Sandra A. Ostoich, Hye R. Kim, Masaki Ueno, Wasat Mansoor, Wen‐Chi Yang, Tianshu Liu, John Bridgewater, Tomoki Makino, Ioannis Xynos, Xuan Liu, Ming Lei, Kaoru Kondo, Apurva Patel, Joseph Gricar, Ian Chau, Yuko Kitagawa

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: